Literature DB >> 8405711

Transforming growth factor-beta 1 enhances glomerular collagen synthesis in diabetic rats.

J S Bollineni1, A S Reddi.   

Abstract

In vitro glomerular collagen synthesis and its response to various concentrations of transforming growth factor-beta 1 were studied in normal and diabetic rats. TGF-beta 1 increased collagen synthesis in normal glomeruli in a dose-dependent manner up to 5 ng/ml. Concentrations > 5 ng/ml showed a gradual decline in collagen synthesis. Basal collagen synthesis was increased in diabetic glomeruli, but addition of TGF-beta 1 had no effect. Antibody to TGF-beta 1 prevented this increase in collagen synthesis. Both circulating TGF-beta 1 concentration and its glomerular expression of mRNA were higher in diabetic than in normal rats. Although addition of TGF-beta 1 did not increase synthesis in vitro, the absence of an effect is consistent with downregulation of its receptors attributable to the high circulating levels. This study clearly indicates a regulatory role of TGF-beta 1 in renal glomerular collagen synthesis in the normal rat, and suggests a possible causal role for enhanced collagen synthesis in the diabetic rat.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405711     DOI: 10.2337/diab.42.11.1673

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.

Authors:  D Koya; M R Jirousek; Y W Lin; H Ishii; K Kuboki; G L King
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 3.  Inflammation and glomerular injury.

Authors:  A Benigni; G Remuzzi
Journal:  Springer Semin Immunopathol       Date:  1994

4.  CCN3/CCN2 regulation and the fibrosis of diabetic renal disease.

Authors:  Bruce L Riser; Feridoon Najmabadi; Bernard Perbal; Jo Ann Rambow; Melisa L Riser; Ernest Sukowski; Herman Yeger; Sarah C Riser; Darryl R Peterson
Journal:  J Cell Commun Signal       Date:  2010-02-09       Impact factor: 5.782

5.  Increased activity of the insulin-like growth factor system in mesangial cells cultured in high glucose conditions. Relation to glucose-enhanced extracellular matrix production.

Authors:  G Pugliese; F Pricci; N Locuratolo; G Romeo; G Romano; S Giannini; B Cresci; G Galli; C M Rotella; U Di Mario
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

6.  Serum Levels of TGF-beta1, TIMP-1 and TIMP-2 in Patients with Lumbar Spinal Stenosis and Disc Herniation.

Authors:  Hyung-Jun Kim; Jong-Beom Park; Ho-Yeon Won; Han Chang
Journal:  Asian Spine J       Date:  2007-06-30

7.  CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.

Authors:  Bruce L Riser; Feridoon Najmabadi; Bernard Perbal; Darryl R Peterson; Jo Ann Rambow; Melisa L Riser; Ernest Sukowski; Herman Yeger; Sarah C Riser
Journal:  Am J Pathol       Date:  2009-04-09       Impact factor: 4.307

8.  Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model.

Authors:  T Ota; T Takamura; H Ando; E Nohara; H Yamashita; K Kobayashi
Journal:  Diabetologia       Date:  2003-05-27       Impact factor: 10.122

Review 9.  Do resident renal mast cells play a role in the pathogenesis of diabetic nephropathy?

Authors:  Pitchai Balakumar; Jayarami Reddy; Manjeet Singh
Journal:  Mol Cell Biochem       Date:  2009-05-05       Impact factor: 3.396

10.  Effect of antisense TGF-beta1 oligodeoxynucleotides in streptozotocin- induced diabetic rat kidney.

Authors:  Hyo Soon Jeong; Kwan Kyu Park; Kwan Kyu Park; Sang Pyo Kim; In Jang Choi; In Kyu Lee; Hyun Chul Kim
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.